fashion -WSS

fashion

author：fashion 2025-09-06 04:42:16 - browse：83

Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels.

On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months. Oncologists are facing critical shortages of common, generic cancer medications and have even begun to ration care for certain patients who are able to delay treatment, according to Rice.

“Patients are already under a lot of stress — they’re dealing with a cancer diagnosis, and they’re terrified. The last thing they want to hear is that something that’s critical to controlling their cancer might not be available, and we’re wondering where the next dose is going to come from,” Rice said.

The conversation is based off Rice’s recent First Opinion, “Cancer drug shortages should have patients rioting in the streets.“

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： NYU radiologists take on the challenge of expensive MRI machines

WSS

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

CDC panel: People 65 and older should get a Covid spring booster shot

Morphosys mixed study results for blood cancer drug

Redefining sustainability for the pharmaceutical industry

Laying a path for careers in science

Hospitals look to new technology to keep health care workers safe

entertainment

fashion

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Pfizer is about to make a big push in cancer. Will investors listen?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Tori Bowie and the unacceptable rates of Black maternal death

'Vaccine

Medicare details structure of new drug price negotiation program

Medicare isn't yet testing food as medicine

Jerome Adams on the need for new antivirals for Covid

CRISPR pioneers react to Casgevy, first gene

hotspot

Medicare Advantage isn’t working — for anyone

Ohio train derailment: Experts on toxic chemical risks

Cholera vaccine supplies dangerously low, outbreaks surging

Morphosys mixed study results for blood cancer drug

CRISPR pioneers react to Casgevy, first gene

Childhood cancer progress stalls for Black, Hispanic kids: Report

hotspot

explore

knowledge

focus